Mcf Advisors LLC Amicus Therapeutics, Inc. Transaction History

Mcf Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$10.96 - $14.4 $2,750 - $3,614	-251 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$10.04 - $13.92 $100 - $139	10 Added 4.15%	251 $3,000
Q4 2018 Jan 25, 2019	SELL	$8.38 - $13.44 $636 - $1,021	-76 Reduced 23.97%	241 $2,000
Q3 2018 Oct 24, 2018	BUY	$11.6 - $16.54 $3,677 - $5,243	317 New	317 $4,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.